Read our Q&A on the decentralized approach
The potential impact on R&D and drug pricing. How can pharma prepare?
Weekly episodes on the latest health trends and policy updates
Now more than ever, Pharmaceutical and Life Sciences companies are under intense and high-profile pressure to introduce new products in an environment of escalating R&D costs, complex science, heightened regulatory scrutiny, and increased competition. Let PwC help as your company shifts attention from diseases that are relatively common and easy to treat to those that are much more complex or unusual.
With end-to-end capabilities—from discovery through product life cycle management—PwC’s R&D team engages across functions to help enable more seamless business operations. Through strategic portfolio, project, and resource planning, predictive research analytics, and quality and compliance solutions to manage regulatory risks proactively, we can help your organization offer increased benefits and value relative to existing therapies while streamlining their processes for efficiency.